Research pinpoints powerful biomarker of Multiple Sclerosis

University of Sydney research in Nature Scientific Reports has found unique molecules in the blood of MS patients could lead to the development of a definitive biomarker diagnosis. A breakthrough study led by the University of Sydney’s Brain and Mind Centre and Royal Prince Alfred Hospital has revealed unique molecules in the blood of people with Multiple Sclerosis (MS) that could become definitive diagnostic biomarkers of the world’s most common neurologic disability in young adults.